REQUEST A DEMO
Total
USD $0.00
Search more companies

Indian Genomix Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Indian Genomix Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Indian Genomix Private Limited is an unlisted company, incorporated on 23/12/1998. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24230TG1998PTC030757 and registration number is 030757. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Headquarters
Plot No. 135/1 & 2 Phase-Ii Ida Cherlapally Hyderabad In 500051
Rangareddy; Andhra Pradesh; Postal Code: 500051

Contact Details: Purchase the Indian Genomix Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Indian Genomix Private Limited report to view the information.
Outstanding Shares:
Purchase the Indian Genomix Private Limited report to view the information.
Registered Capital:
Purchase the Indian Genomix Private Limited report to view the information.
Incorporation Date:
December 23, 1998
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
45.85%
Purchase this report to view the information.
2.08%
Company Performance
Financial values in the chart are available after Indian Genomix Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
13.87%
Total operating revenue
13.99%
Operating profit (EBIT)
9.96%
EBITDA
3.22%
Net Profit (Loss) for the Period
4.78%
Total assets
11.34%
Total equity
2.63%
Operating Profit Margin (ROS)
-0.07%
Net Profit Margin
-0.09%
Return on Equity (ROE)
0.05%
Debt to Equity Ratio
28.16%
Quick Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?